Rizatriptan
From Free net encyclopedia
Revision as of 11:40, 11 February 2006; view current revision
←Older revision | Newer revision→
←Older revision | Newer revision→
Image:Rizatriptan.png Rizatriptan (Maxalt®) is a triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).
Maxalt obtained approval by the FDA on June 29, 1998.
Rizatriptan is available only by prescription in the United States and Canada.
This medication is used to treat acute migraine attacks. This drug does not prevent future migraine attacks.
[edit]
External links
- Maxalt Official homepage by Merck & Co.
- Maxalt Information Fact Sheet
- Rizatriptan
| Triptans edit |
|---|
|
Almotriptan | Eletriptan | Frovatriptan | Naratriptan | Rizatriptan | Sumatriptan | Zolmitriptan |